Can a med spa in New Jersey offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
⚠️ New Jersey bars compounded sterile stock for human practice, and permits it for animals. “in the absence of a valid patient-specific prescription or medication order, pharmacists, pharmacy technicians, pharmacy interns, and pharmacy externs shall not prepare compounded sterile preparations for human use for a licensed prescriber to use in his or her practice, except to the extent permitted by federal law.” The very next sentence lets a pharmacy prepare them for a prescriber “for non-human use … without a prescription”. The federal exception is the 503B door.
N.J.A.C. 13:39-11.18 · verified Sep 2, 2026 · regulatory monitoring, not legal advice
Related New Jersey rules
⚠️ and compounding a drug you could buy needs one of two justifications. “a pharmacist shall not compound any commercially available drug products unless: 1) The commercially available product is modified to produce a significant difference, in the professional judgment of the prescriber, between the compounded product for the patient and the comparable commercially available product; OR 2) The commercially available product is not available from normal distribution channels in a timely manner to meet the patient’s needs, AND the dispensing of the compounded product has been approved by the prescriber and the patient.” Note route 2 needs the PATIENT’s approval as well as the prescriber’s.
N.J.A.C. 13:39-11.25(b) · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule
And the reason must be written down: “a pharmacist who compounds a commercially available product consistent with the requirements of (b) above shall maintain documentation of the reason for such compounding.” Separately, a pharmacist “shall not compound preparations that contain drug products that appear on the federal food and drug administration’s list of drug products withdrawn or removed from the market for reasons of safety or effectiveness” at 21 CFR 216.24.
N.J.A.C. 13:39-11.25(a), (c) · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related New Jersey questions
- Is an exam required before a patient can be treated in New Jersey?
- Can the pre-treatment exam be done by telehealth in New Jersey?
Get New Jersey changes as they publish
We scan the New Jersey legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All New Jersey rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).